Hi-Risk/Recurrent/Advanced PrCa Video Chat, Nov 10, 2026

by | Nov 11, 2026 | High Risk/Recurrent/Advanced, High Risk/Recurrent/Advanced Prostate Cancer, mCRPC, mHSPC, Prostate Cancer, Recorded Groups, Uncategorized

Intermediate Risk Prostate Cancer Graphic

Hi-Risk/Recurrent/Advanced PrCa Video Chat, Nov 10, 2026

 

AnCan IS ON SUBSTACK… find us at https://ancanspeak.substack.com/. Please sign up. We’re posting the best of all our Reminders.

AnCan thanks the following sponsors for making this recording possible: Novartis, Telix and Blue Earth Diagnostics.
Views expressed in this Recording are solely the opinion of AnCan Foundation, our Moderators and Participants.

AnCan does not accept sponsored promotion. Any drugs, protocols or devices discussed are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.

AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download

All AnCan’s groups are free and drop-in … join us in person sometime! You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/ Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/

Join our other free and drop in groups:
Men (Only) Speaking Freely…1st & 3rd Thursdays @ 8.00 pm Eastern https://ancan.org/men-speaking-freely/
Veterans Healthcare Navigation… 1st & 3rd Tuesdays @ 8.00 pm Eastern Schmier Room https://ancan.org/veterans/
Veterans Speaking freely… 4th Tuesday @ @ 8.00 pm Eastern Schmier Room

Editor’s Pick:  Dr. Paul provides sage advice more than once but can’t prevent his E2 getting aced out by Veozah!

Topics Discussed

Treatment decision for newly Dx high risk, 72 yr old Newbie; Dr. Paul has thoughts on RT vs surgery; one of our Mods faces Tx decision for a single lymph node lesion; Dr. Paul comments further on surgical removal and also nerve sparing surgery; darolutamide and fatigue; urinary issues post-RT; Andromeda trial completed with a few more side effects; T comes back and PSA stays low post RT + HT; getting off daro to stay in ‘The Long Game’ study; should denosumab be capped off with a bisphosphonate/; considering the LEGION-100 SYNC-T trial… again; Veozah works a charm

Chat

  • rick davis sent: 4:27 PM

    Brachytherapy

    Amar Kishan https://www.uclahealth.org/providers/amar-kishan

    FYI Dr. Paul is a former President of the American Urology Association

  • Danny Lankford sent: 4:39 PM

    Love hearing your thought processes and logic, Dr. Paul.

  • Bob Y — Los Angeles sent: 4:39 PM

    Rick, Do you have the name of a medical oncologist in San Diego that you might recommend for Bob?

  • rick davis sent: 4:40 PM

    by far and away the best is Rana McKay at UCSD https://profiles.ucsd.edu/rana.mckay

  • Bob Y — Los Angeles sent: 4:41 PM

    Excellent.

  • Bob McHugh sent: 4:45 PM

    Same here with Daro.

  • rick davis sent: 5:06 PM

    Zakim https://www.dana-farber.org/patient-family/support-services/integrative-therapies

  • Morgan Brooke sent: 5:14 PM

    Could you send a link to the trial? I think I missed the trial name

  • jeff wood sent: 5:15 PM

    David thank you for getting out there on future treatments for us all

  • rick davis sent: 5:15 PM

    Andromeda https://clinicaltrials.gov/study/NCT07150715?tab=study

  • David sent: 5:21 PM

    Coordinator for Andromeda Trial Sophia Parmisano (she/her) Clinical Research Coordinator UCLA Dept. of Radiation Oncology Ph: (310) 267-3169 200 Medical Plaza, Suite B265 Los Angeles, CA 90095-6951

  • Bruce C sent: 5:27 PM

    legion 100

  • Len Sierra sent: 5:27 PM

    LEGION-100 Clinical Trial ClinicalTrials.gov ID Number: NCT06533644 This clinical trial is studying an investigational therapy called SYNC-T Therapy SV-102. It is a combination therapy that freezes a portion of a tumor and then infuses a drug directly into the tumor. The therapy is designed to activate the immune system and enable it to fight cancer throughout the body.

  • rick davis sent: 5:35 PM

    Sat Sep 19h High Risk/Rec/Adv PrCa. Reminder…. The Abscopal Effect Done with Class!

  • Mark sent: 5:52 PM

    Not tonight, thanks

    Lymph node was not accessible

  • Danny Lankford sent: 5:54 PM

    I will receive monthly liver enzyme testing

  • Bruce Schrimpf sent: 5:54 PM

    Great session guys! I found it very good this evening!